Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Inotrem
Biotech
Inotrem posts 2nd data drop of the month, this time for COVID
French biotech Inotrem posted phase 2 data showing its only clinical-stage compound nangibotide could help treat critically ill COVID-19 patients.
Gabrielle Masson
Oct 25, 2022 2:00am
Inotrem sparks hope with new phase 2b data
Oct 13, 2022 12:20pm
Zimmermann replaces ex-Roche pRED chief as Inotrem CEO
Mar 24, 2021 8:50am
Roche, Inotrem extend collaboration on septic shock test
Jan 21, 2020 11:50am
Roche pens septic shock diagnostic pact
Nov 10, 2017 7:30am
